isoborneol has been researched along with Idiopathic Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, L; Liu, R; Song, Y; Sun, K; Tang, S; Wang, A; Wu, Z; Xue, P; Yan, X; Yang, X; Yu, X | 1 |
1 other study(ies) available for isoborneol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease.
Topics: Administration, Intranasal; Animals; Antiparkinson Agents; Brain; Camphanes; Cells, Cultured; Dopamine; Drug Delivery Systems; Lactoferrin; Nanoparticles; Parkinson Disease; Rats; Rats, Sprague-Dawley | 2019 |